News about Global Pharma

EMA Approves Dupixent as First-Ever Targeted Therapy for Patients with COPD

The European Medicines Agency (EMA) has recently announced their approval for Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.

Global Pharma | 04/07/2024 | By Aishwarya |  695

Heron Therapeutics Announces Acceptance of the PAS Application for ZYNRELEF

Heron Therapeutics, Inc. has announced that the FDA acknowledged the receipt of the company's Prior Approval Supplement (PAS) application for ZYNRELEF (bupivacaine and meloxicam) extended-release solution VAN.

Global Pharma | 04/07/2024 | By Aishwarya |  683

Tobin Scientific Announces Acquisition of BioRepository Resources

Tobin Scientific has acquired BioRepository Resources LLC (BRR), a leader in biological sample storage and management solutions, located in New Providence, New Jersey.

Global Pharma | 03/07/2024 | By Aishwarya |  1109

Techinvention Lifecare Joins BVI as Consultant for Veterinary Vaccine Manufacturing Facility

Techinvention Lifecare Pvt. Ltd. has announced its appointment as a consultant by Botswana Vaccine Institute (BVI) to monitor the setting up of the new state-of-the-art and cGMP-compliant, vaccine manufacturing unit in its existing facility at Gaborone, Botswana.

Global Pharma | 03/07/2024 | By Aishwarya |  526

Genezen to Acquire uniQure Commercial Gene Therapy Manufacturing Operations in Lexington

Genezen has inked an agreement to acquire uniQure's commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company.

Global Pharma | 02/07/2024 | By Aishwarya |  915

Anbogen Therapeutics Secures Additional USD 7.3 Million in A+ Round Financing

Anbogen Therapeutics, Inc. has received USD 7.3 million oversubscribed A+ round financing, which is a direct continuation of the USD 12.5 Million Series A on February 1, 2024, bringing the total raised to USD 19.8 million.

Global Pharma | 02/07/2024 | By Aishwarya |  1148

Avanos Medical Appoints Indrani Franchini to Board of Directors

Franchini served as Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals. From June 2017 to July 2021, she served as Executive Vice President and Chief Compliance Officer at Alexion Pharmaceuticals, Inc., where she led a comprehensive transformation of the company's compliance program.

Global Pharma | 01/07/2024 | By Manvi |  238

TruDiagnostic Introduces Organ-Specific Aging Analysis from SYMPHONYAge Algorithms

TruDiagnostic has developed epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.

Global Pharma | 01/07/2024 | By Aishwarya |  1841

AbbVie Announces Acquisition of Celsius Therapeutics

AbbVie has acquired Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease.

Global Pharma | 29/06/2024 | By Aishwarya |  1073

Emcure Plans for Expansion and New Acquisitions with Upcoming IPO

Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.

Global Pharma | 29/06/2024 | By Aishwarya |  1860